Evolution of Antipsychotic Intervention in the Schizophrenic Psychosis
Journal:
Current Drug Targets
Volume:
7
Page:
1205-1215
Author(s):
David L. Garver
Assessment of Selective Homing and Contribution to Vessel Formation of Cryopreserved Peripherally Injected Bone Marrow Mononuclear Cells Following Experimental Myocardial Damage
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
6
Page:
141-149
Author(s):
M. M. Ciulla, S. Ferrero, E. Montelatici, U. Gianelli, P. Braidotti, S. Calderoni, R. Paliotti, G. Annoni, E. De Camilli, G. Busca, F. Magrin, S. Bosari, L. Lazzari and P. Rebulla
Nutritional Control, Gene Regulation, and Transformation of Vascular Smooth Muscle Cells in Atherosclerosis
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
6
Page:
151-168
Author(s):
A. Linares, S. Perales, R. J. Palomino-Morales, M. Castillo and M. J. Alejandre
Physiological and Pharmacological Insights into the Role of Ionic Channels in Cardiac Pacemaker Activity
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
6
Page:
169-190
Author(s):
B. Couette, L. Marger, J. Nargeot and M. E. Mangoni
Development of Monoclonal Antibodies that Inhibit Platelet Adhesion or Aggregation as Potential Anti-Thrombotic Drugs
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
6
Page:
191-207
Author(s):
S. F. De Meyer, K. Vanhoorelbeke, H. Ulrichts, S. Staelens, H. B. Feys, I. Salles, A. Fontayne and H. Deckmyn
Novel Agents to Manage Dyslipidemias and Impact Atherosclerosis
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
6
Page:
209-217
Author(s):
S. Nachimuthu and P. Raggi
Vasculogenesis of the Embryonic Heart: Contribution of Nucleated Red Blood Cells to Early Vascular Structures
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
6
Page:
219-225
Author(s):
A. Ratajska and E. Czarnowska
Editorial [Hot Topic: Phosphodiesterase 5 Inhibitors: Pharmacology and Therapeutic Perspectives (Executive Editor: Giuseppe Barbaro)]
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3437-3437
Author(s):
Giuseppe Barbaro
Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3467-3484
Author(s):
Antonio Aversa, Roberto Bruzziches, Marcello Pili and Giovanni Spera
Cardiovascular Effects of Phosphodiesterase 5 Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3485-3494
Author(s):
Thorsten Reffelmann and Robert A. Kloner